Evidence map›Paper›PMID 30704100›Full record

ArticleInternational journal of molecular sciences2019

Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.

Axel Haarmann, Michael K Schuhmann, Christine Silwedel, Camelia-Maria Monoranu, Guido Stoll, Mathias Buttmann

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Interleukin-8 in health and disease.Molecular biomedicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Acute severe hypoglycemia alters mouse brain microvascular proteome.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The immunological function of CXCR2 in the liver during sepsis.Journal of inflammation (London, England) · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Axel HaarmannDepartment of Neurology, University of Würzburg, 97080 Würzburg, Germany. haarmann_a@ukw.de.
Michael K SchuhmannDepartment of Neurology, University of Würzburg, 97080 Würzburg, Germany. schuhmann_m@ukw.de.
Christine SilwedelUniversity Children's Hospital, University of Würzburg, 97080 Würzburg, Germany. silwedel_c@ukw.de.
Camelia-Maria MonoranuDepartment of Neuropathology, University of Würzburg, 97080 Würzburg, Germany. camelia-maria.monoranu@uni-wuerzburg.de.
Guido StollDepartment of Neurology, University of Würzburg, 97080 Würzburg, Germany. stoll_g@ukw.de.
Mathias ButtmannDepartment of Neurology, University of Würzburg, 97080 Würzburg, Germany. m.buttmann@uni-wuerzburg.de.ORCID 0000-0001-8309-7685
University of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokines (C-X-C) motif ligand (CXCL) 5 and 8 are overexpressed in patients with multiple sclerosis, where CXCL5 serum levels were shown to correlate with blood-brain barrier dysfunction as evidenced by gadolinium-enhanced magnetic resonance imaging. Here, we studied the potential role of CXCL5/CXCL8 receptor 2 (CXCR2) as a regulator of paraendothelial brain barrier function, using the well-characterized human cerebral microvascular endothelial cell line hCMEC/D3. Low basal CXCR2 mRNA and protein expression levels in hCMEC/D3 were found to strongly increase under inflammatory conditions. Correspondingly, immunohistochemistry of brain biopsies from two patients with active multiple sclerosis revealed upregulation of endothelial CXCR2 compared to healthy control tissue. Recombinant CXCL5 or CXCL8 rapidly and transiently activated Akt/protein kinase B in hCMEC/D3. This was followed by a redistribution of tight junction-associated protein zonula occludens-1 (ZO-1) and by the formation of actin stress fibers. Functionally, these morphological changes corresponded to a decrease of paracellular barrier function, as measured by a real-time electrical impedance-sensing system. Importantly, preincubation with the selective CXCR2 antagonist SB332235 partially prevented chemokine-induced disturbance of both tight junction morphology and function. We conclude that human brain endothelial CXCR2 may contribute to blood-brain barrier disturbance under inflammatory conditions with increased CXCL5 and CXCL8 expression, where CXCR2 may also represent a novel pharmacological target for blood-brain barrier stabilization.

Indexed as

Blood-Brain BarrierBlotting, WesternCell LineChemokine CXCL5Endothelial CellsEndothelium, VascularHumansImmunohistochemistryInterleukin-8Real-Time Polymerase Chain ReactionReceptors, Interleukin-8BTumor Necrosis Factor-alphaZonula Occludens-1 ProteinChemokine CXCL5CXCL5 protein, humanCXCL8 protein, humanCXCR2 protein, humanInterleukin-8Receptors, Interleukin-8BTJP1 protein, humanTumor Necrosis Factor-alphaZonula Occludens-1 Proteinblood–brain barrierCXCL5CXCL8CXCR2human cerebral endothelial cellsinterleukin-8multiple sclerosisSB332235

Identifiers

PMID30704100
PMCPMC6387364
OpenAlexW2914097882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.